Sibold William John 4

What Happened

• William John Sibold, President & CEO and a Director of Madrigal Pharmaceuticals (MDGL), sold 1,577 shares on 2026-01-26 at $492.42 per share, generating about $776,546. This was a sale (S) and not a new purchase, and it reflects a routine disposition rather than an expressed market view.

Key Details

• Transaction date and price: 2026-01-26, 1,577 shares at $492.42 each.
• Total proceeds: approximately $776,546.
• Shares owned after transaction: not provided in the supplied filing summary.
• Footnote: The sale was automatic to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs); it was not at the Reporting Person’s discretion (per footnote F1).
• Filing timing: Reported on Form 4 with the same report date (2026-01-26), indicating the filing was made the same day as the reported transaction.

Context

• This was a tax-withholding/cashless-type sale tied to RSU vesting, a common administrative action that does not necessarily signal bullish or bearish intent by the insider. Retail investors typically weight purchases more heavily than routine withholding sales when assessing insider sentiment.